24 research outputs found

    Design Principle of Conjugated Polyelectrolytes to Make Them Water‐Soluble and Highly Emissive

    Full text link
    The correlation between the molecular design of a conjugated polyelectrolyte (CPE) and its aggregated structure and the emissive properties in water is systematically investigated by means of UV–vis spectrometry, fluorescence spectroscopy, and scanning/transmission electron microscopy. Five different and rationally designed CPEs having carboxylic acid side chains are synthesized. All five conjugated polyelectrolytes are seemingly completely soluble in water in visual observation. However, their quantum yields are dramatically different, changing from 0.45 to 51.4%. Morphological analysis by electron microscopy combined with fluorescence spectrophotometry reveals that the CPEs form self‐assembled aggregates at the nanoscale depending on the nature of their side chains. The feature of the self‐assembled aggregates directly determines the emissive property of the CPEs. The nature and the length of the spacer between the carboxylic acid group and the CPE backbone have a strong influence on the quantum yield of the CPEs. Our study demonstrates that bulky and hydrophilic side chains and spacers are required to achieve complete water‐solubility and high quantum yield of CPEs in water, providing an important molecular design principle to develop functional CPEs. The correlation between the molecular design of conjugated polyelectrolytes (CPEs) and their solubility and emissive properties in water is systematically investigated by means of UV–vis and fluorescence spectroscopy and electron microscopy. Bulky and hydrophilic side chains and spacers are required to achieve complete water solubility and high quantum yield of CPEs in water, providing an important molecular design principle to develop functional CPEs.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90088/1/1076_ftp.pd

    The benzene metabolite para-benzoquinone is genotoxic in human, phorbol-12-acetate-13-myristate induced, peripheral blood mononuclear cells at low concentrations

    Get PDF
    Benzene is one of the most prominent occupational and environmental pollutants. The substance is a proven human carcinogen that induces hematologic malignancies in humans, probably at even low doses. Yet knowledge of the mechanisms leading to benzene-induced carcinogenesis is still incomplete. Benzene itself is not genotoxic. The generation of carcinogenic metabolites involves the production of oxidized intermediates such as catechol, hydroquinone and para-benzoquinone (p-BQ) in the liver. Further activation to the ultimate carcinogenic intermediates is most probably catalyzed by myeloperoxidase (MPO). Yet the products of the MPO pathway have not been identified. If an oxidized benzene metabolite such as p-BQ was actually the precursor for the ultimate carcinogenic benzene metabolite and further activation proceeds via MPO mediated reactions, it should be possible to activate p-BQ to a genotoxic compound in vitro. We tested this hypothesis with phorbol-12-acetate-13-myristate (PMA) activated peripheral blood cells exposed to p-BQ, using the cytokinesis-block micronucleus test. Addition of 20–28 ng/ml PMA caused a significant increase of micronuclei at low and non-cytotoxic p-BQ concentrations between 0.04 and 0.2 μg/ml (0.37–1.85 μM). Thus with PMA or p-BQ alone no reproducible elevation of micronuclei was seen up to toxic concentrations. PMA and p-BQ induce micronuclei when administered jointly. Our results add further support to the hypothesis that MPO is a key enzyme in the activation of benzene

    Neutrinos

    Get PDF
    229 pages229 pages229 pagesThe Proceedings of the 2011 workshop on Fundamental Physics at the Intensity Frontier. Science opportunities at the intensity frontier are identified and described in the areas of heavy quarks, charged leptons, neutrinos, proton decay, new light weakly-coupled particles, and nucleons, nuclei, and atoms

    Understanding the High Creep Resistance of MRI 230D Magnesium Alloy through Nanoindentation and Atom Probe Tomography

    No full text
    Due to their low density, magnesium alloys are very appealing for light-weight constructions. However, the use of the most common magnesium alloy, AZ91 (Mg 9 wt.% Al, 1 wt.% Zn), is limited to temperatures below 150 °C due to creep failure. Several alloys with an improved creep resistance have been developed in the past, for example the alloy MRI 230D or Ca-alloyed AZ91 variants. However, there is an ongoing discussion in the literature regarding the mechanisms of the improved creep resistance. One factor claimed to be responsible for the improved creep resistance is the intermetallic phases which form during casting. Another possible explanation is an increased creep resistance due to the formation of precipitates. To gain more insight into the improved creep resistance of MRI 230D, nanoindentation measurements have been performed on the different phases of as-cast, creep-deformed and heat-treated samples of MRI 230D and Ca-alloyed AZ91 variants. These nanoindentation measurements clearly show that the intermetallic phase (IP) of the alloy MRI 230D does not lose strength during creep deformation in contrast to the Ca-alloyed AZ91 variants. High-temperature nanoindentation measurements performed at 200 °C clearly show that the intermetallic phases of the MRI 230D alloy maintain their strength. This is in clear contrast to the Ca-alloyed AZ91 variants, where the IP is significantly softer at 200 °C than at room temperature. Atom probe measurements have been used to gain insight into the differences in terms of chemical composition between the IPs of MRI 230D and the Ca-alloyed AZ91 variants in order to understand the dissimilar behaviour in terms of strength loss with increasing temperature

    Microbial IgA Protease Removes IgA Immune Complexes from Mouse Glomeruli In Vivo: Potential Therapy for IgA Nephropathy

    No full text
    The hallmark of IgA nephropathy (IgAN), the most common form of glomerulonephritis, is the presence of mesangial deposits containing IgA, specifically the IgA1 subclass, as the most prominent component. The deposited IgA is considered to be part of an immune complex. The family of enzymes known as bacterial IgA proteases exhibits substrate specificity that is essentially limited to the hinge region of IgA1. Here we demonstrate the ability of systemically administered IgA protease to remove glomerular IgA immune complexes, both the antigen and antibody components, in a passive mouse model of IgAN. Thus, IgA protease may have potential as a therapeutic agent for human IgAN
    corecore